AUTOINJEKTOR

European patent · EP3019218 · In force

Register entry

Publication number
EP3019218
Application number
EP14737211
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jul 7, 2014
Published
May 18, 2016
Granted
May 27, 2020
Protection ends at the latest
Jul 6, 2034
Next annual fee due
Jul 31, 2027
IPC classes
A61M 5/20 (2006.01)
A61M 5/32 (2006.01)
Priority
EP 13175662 09.07.2013
PCT application
PCT/EP2014/064425 07.07.2014
PCT publication
WO2015/004050 15.01.2015
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.07.2026 → 31.07.2027

    Published in Swissreg on 01.08.2026

  2. Aug 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.07.2025 → 31.07.2026

    Published in Swissreg on 01.08.2025

  3. Aug 1, 2024

    Change

    Published in Swissreg on 01.08.2024

  4. Aug 1, 2023

    Change

    Published in Swissreg on 01.08.2023

  5. Aug 1, 2022

    Change

    Published in Swissreg on 01.08.2022

  6. May 27, 2020

    Granted

    Published in Swissreg on 27.05.2020

Parties

Holder

Sanofi-Aventis Deutschland GmbH

Brüningstraße 50, 65929 Frankfurt am Main, DE

Inventor

KEMP, Thomas

Ashwell Hertfordshire SG7 5LU, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.